Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 5038 for:    colon cancer

Length of Tumour Feeding Artery After Colon Cancer Surgery (ColonCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02164149
Recruitment Status : Unknown
Verified June 2014 by University of Aarhus.
Recruitment status was:  Recruiting
First Posted : June 16, 2014
Last Update Posted : June 16, 2014
Sponsor:
Information provided by (Responsible Party):
University of Aarhus

Tracking Information
First Submitted Date June 2, 2014
First Posted Date June 16, 2014
Last Update Posted Date June 16, 2014
Study Start Date May 2014
Estimated Primary Completion Date November 2014   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 12, 2014)
CT scan after colon cancer surgery. The length of the tumour feeding artery will be measured on the images. [ Time Frame: 6 to 9 months ]
Patients will have an extra CT scan two days after surgery.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Length of Tumour Feeding Artery After Colon Cancer Surgery
Official Title Length of Tumour Feeding Artery After Colon Cancer Surgery
Brief Summary

The quality of colon cancer surgery is highly debated these years since the mortality of the disease is not declining markedly. Surgery is the main treatment of colon cancer and during surgery it is very important for the surgeon to remove the tumour and all potential ways of tumour spread. As colon cancer first of all spreads to the nearby lymph nodes lying along the tumour feeding artery the surgeon aims to cut the vessel as central as possible. This means that all of the tumour feeding artery should have been removed after surgery.

In this study the investigators want to measure the length of the tumour feeding artery after surgery as a quality control of the surgery. The investigators hypothesize that the artery will be shorter than 5 mm.

The investigators wish to CT scan all patients two days after colon cancer surgery and afterwards measure then length of the artery on the images. This study will not inflict with the normal routine for patient information and treatment.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All patients over 18 years with primary colon cancer, who are to have surgery at Randers Regional Hospital, Denmark.
Condition Colon Cancer
Intervention Other: Patients with primary colon cancer
CT scan two days after surgery
Study Groups/Cohorts Quality of colon cancer surgery
Patients with primary colon cancer
Intervention: Other: Patients with primary colon cancer
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: June 12, 2014)
65
Original Estimated Enrollment Same as current
Estimated Study Completion Date November 2015
Estimated Primary Completion Date November 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Primary colon cancer

Exclusion Criteria:

  • Kidney failure, allergy to contrast, pregnancy
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Denmark
Removed Location Countries  
 
Administrative Information
NCT Number NCT02164149
Other Study ID Numbers CT121177
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party University of Aarhus
Study Sponsor University of Aarhus
Collaborators Not Provided
Investigators
Study Director: Soren Laurberg, Professor Aarhus University Hospital
PRS Account University of Aarhus
Verification Date June 2014